Why the study?
Data are lacking regarding the safety and survival outcomes after surgical ablation concomitant to minimally invasive mitral valve surgery in patients with AF.
Does surgical ablation concomitant to minimally invasive mitral valve surgery improve survival and reduce complications in adult patients with atrial fibrillation?
Population
1,545 adult AF patients undergoing MIMVS (365 propensity score-matched pairs)
Comparison
MIMVS with concomitant surgical ablation vs MIMVS alone
Design
Retrospective national registry-based propensity score-matched study
Key result
Surgical ablation during minimally invasive mitral valve surgery did not significantly improve adjusted long-term survival (HR 0.85; 95% CI 0.56-1.32; P=0.48), but was associated with fewer neurologic complications.
Authors
Loading...
May reduce neurologic complications in AF patients undergoing MIMVS; leaves open adjusted survival benefit in this observational cohort.
Cohort (n=1,545)
Yes
Does surgical ablation concomitant to minimally invasive mitral valve surgery improve survival and reduce complications in adult patients with atrial fibrillation?
Hazard Ratio: 0.85 (95% CI 0.56–1.32)
p-value: p=0.48
Concomitant surgical ablation during minimally invasive mitral valve surgery in AF patients reduces neurologic complications and may offer survival benefits specifically in those with high thromboembolic risk.
Kowalewski et al. (2026) conducted a cohort in Atrial fibrillation and mitral valve disease (n=1,545). Surgical ablation vs. Minimally invasive mitral valve surgery alone was evaluated on Long-term survival (adjusted) (HR 0.85, 95% CI 0.56-1.32, p=0.48). Surgical ablation during minimally invasive mitral valve surgery did not significantly improve adjusted long-term survival (HR 0.85; 95% CI 0.56-1.32; P=0.48), but was associated with fewer neurologic complications.